GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:ATHJF) » Definitions » Institutional Ownership

Percheron Therapeutics (Percheron Therapeutics) Institutional Ownership : 0.03% (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Percheron Therapeutics's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Percheron Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Percheron Therapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.

Percheron Therapeutics Institutional Ownership Historical Data

The historical data trend for Percheron Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Institutional Ownership Chart

Percheron Therapeutics Historical Data

The historical data trend for Percheron Therapeutics can be seen below:

2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31 2022-02-28
Institutional Ownership 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03

Percheron Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Percheron Therapeutics (Percheron Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:ATHJF) » Definitions » Institutional Ownership
Comparable Companies
ASX:LV1 ASX:NXS ASX:MVP ASX:LGP ASX:VIT ASX:IVX ASX:EOF ASX:ECS ASX:CAN ASX:IDT ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
AWY0:Germany PER:Australia
Address
14 Wallace Avenue, Toorak, VIC, AUS, 3142
Website
https://www.antisense.com.au
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals. The company operates in two segments that have been identified based on its antisense oligonucleotide products as ATL1102 and ATL1103.